Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Staphylococcus aureus
Pharma
FDA OKs Basilea's antibiotic Zevtera for 3 types of infections
The FDA has approved Basilea Pharmaceutica’s antibiotic Zevtera (ceftobiprole) for three different kinds of infections.
Kevin Dunleavy
Apr 4, 2024 8:45am
Pfizer cans $500M staph vaccine after phase 2b trial failure
Jan 30, 2019 9:20am
Could a trio of new vaccines make up for Prevnar at Pfizer?
May 7, 2018 12:30pm
Pfizer R&D chief sees pipeline shots filling Prevnar decline
Apr 10, 2018 10:10am
Pfizer's Prevnar posts big Q4, beating consensus by 10%
Jan 31, 2018 5:00pm
